OPKO Health Inc OPK
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1995-11-02 |
| Shares Out. | 746,330,000 |
| Website | opko.com/ โ |
| Phone | 13026365400 |
| Employees | 2,275 |
| Revenue | $163.6M |
| Gross Profit | $80.0M |
| Net Income | -$8.4M |
| Free Cash Flow | -$134.0M |
| Total Assets | $1.83B |
| Total Liabilities | $645.3M |
| Equity | $1.18B |
About OPKO Health Inc
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
OPKO Health Inc is a publicly traded company under the ticker symbol OPK on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
10 analysts (2026-07-01)

